To get the most out of it, follow the right dose as advised by your doctor
The intervention group demonstrated a 42.2% reduction in headache risk at three months (RR 0.578, 95% CI 0.5020.665, p=0.0001), with continued benefit showing a 28.2% risk reduction at 24-months (RR 0.718, 95% CI 0.6530.788, p=0.0001)
Record the Injection: Keep a record of the date, time, and location of each injection, as advised by your healthcare provider
If you need an assistance or have questions for above drug please contact Aark at E mail: [email protected] or give us a call at M: +91 9999156233 / (+91) 99534-66646
These nano-based strategies not only optimize pharmacokinetics and therapeutic efficacy, but also hold potential for non-invasive delivery routes, including oral, buccal, transdermal, and pulmonary administration